Zeng L, Yang K, Yu G et al (2024) Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases
Recent, as yet fragmentary evidence suggests that intervention with GLP1-RA, e.g., liraglutide, may reduce body weight and improve hyperandrogenism and menstrual irregularities in women with obesity and PCOS 28,29,30,31,32
CJC-1295 without DAC: dosing cadence resembles ipamorelin (multiple subcutaneous administrations per day) because, without the DAC moiety, the half-life collapses to roughly 30 minutes

In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death.161 In summary, dual and triple agonists related to GLP-1 represent significant advances in the field of diabetes treatment,167,168 demonstrating the future trend of enhancing therapeutic effects by targeting multiple biomarkers.136,169,170 With the accumulation of more clinical data and the development of new drugs, these treatment options are expected to provide more effective and comprehensive treatment choices for diabetes patients.161,167 GLP-1 .124,125,126 , , .43 , .127,128 GLP-1R .124,129 GLP-1 GIP .130 , ( Mounjaro) GLP-1 GIPR .124 GLP-1 .131,132,133 , GLP-1 .121,134 GIP , GLP-1 .125,130 2022, 2 FDA .135,136 , .135 , T2DM .136,137,138 , .139,140,141 , .141 , .141,142 3 , , 7 77 .143 2 , .143 , 2
Collect powder into sealed waste container